Latest Options News

Accelerate Resources has advanced its gold exploration at Balagundi and manganese prospects in Pilbara, bolstered by a $900,000 capital raise and a strategic joint venture at the Comet Gold Project.

Anteris Technologies Global Corp. has entered a material definitive agreement to raise approximately $320 million through a public offering and a strategic private placement with Medtronic’s subsidiary. The capital will support clinical trials and manufacturing expansion for its innovative heart valve technology.

Falcon Metals has reported compelling high-grade gold results from its Blue Moon project in Victoria, extending mineralisation along strike and confirming the potential for a significant new gold reef. The company also advances exploration at Pyramid Hill and Errabiddy while maintaining a strong cash position.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

Nyrada Inc. has secured ethics approval to launch a Phase IIa clinical trial for its heart attack drug Xolatryp®, with patient recruitment set for March 2026. The company maintains a solid cash position of AU$7.12 million as it expands its research into oncology.

Arovella Therapeutics has filed an IND application for its lead CAR-iNKT therapy ALA-101, selected a CRO for its upcoming phase 1 trial, and secured $19.4 million in cash to fund clinical progress and pipeline expansion.

Venus Metals Corporation progresses its Sandstone Bellchambers gold project with a new mining lease and exploration targets, while extending its Bridgetown JV farm-in and navigating an unsolicited takeover offer.

Dalaroo Metals is fast-tracking its 2026 exploration program at the Blue Lagoon project in Greenland following promising 2025 results that confirmed widespread rare earth and critical mineralisation. The company aims to define drill-ready targets and advance its position in the strategic critical minerals sector.

Coventry Group reports a solid half-year sales and earnings improvement while initiating a strategic review following unsolicited takeover interest.

SSH Group Ltd reports a robust half-year performance with revenue up 25%, operational advances in gold projects, and a new strategic partnership enhancing its mining capabilities.

Lindian Resources has accelerated development at its Kangankunde Rare Earths Project, securing full ownership and awarding key construction contracts, while attracting strategic international attention.

Neometals has reported promising gold assay results from its Barrambie drilling program and secured substantial conditional funding for its Vanadium Recovery Project in Finland, while progressing new critical minerals opportunities in the US.